News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Amol Galande

Amol Galande is senior manager of the process development laboratory at Lupin Pharmaceuticals

Articles by Amol Galande

Assessing Legacy Drug Quality; image: thodonal - stock.adobe.com

Assessing Legacy Drug Quality

ByAjay Pazhayattil,Sanjay Sharma,Amol Galande,Marzena Ingram,Robert Rhoades

July 2nd 2021

A data-driven strategy can assess the quality of legacy drugs developed before 2011 process-validation requirements were established.

Latest Updated Articles

Assessing Legacy Drug Quality
July 2nd 2021

Trending on Pharmaceutical Technology

PharmTech Weekly Roundup—June 5, 2026

A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision

Tom Sellig on CDMO Innovation and US Manufacturing Growth

EMA Collaborates with African Regulators on Ebola Treatments

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance